THERAPEUTIC AGENT FOR HYPERLIPIDEMIA

Details for Australian Patent Application No. 2002251919 (hide)

Owner SUMITOMO PHARMACEUTICALS COMPANY, LIMITED TULARIK INC.

Inventors NITA, Masahiro; SHAN, Bei; TOJO, Shinichiro; NISHIMURA, Takeski

Pub. Number AU-A-2002251919

PCT Pub. Number WO2002/064125

Priority 09/782,535 13.02.01 US

Filing date 12 February 2002

Wipo publication date 28 August 2002

International Classifications

G01N 033/00 Investigating or analysing materials by specific methods not covered by groups

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 031/575 - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 031/00

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-A-2002251919

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002251920-SYSTEM AND METHOD FOR OPTIMIZING EFFICIENCY OF REPLICATED NETWORK SERVICES

2002251918-SPILL-RESISTANT CONTAINER WITH REINFORCED COLD PLUG